P139 Microbial community composition and patient reported symptoms in cystic fibrosis
Katherine O’Neill, Michael M. Tunney(Queen's University Belfast), D.F. Gilpin(Queen's University Belfast), S. McGrath, J.S. Elborn(Royal Brompton Hospital), C. McGettigan, Laura J. Sherrard, L. McIlreavey, G.G. Einarsson, Emma Johnson(University of Dundee)
Cited by 0
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
Anti-Müllerian Hormone Is a Marker of Gonadotoxicity in Pre- and Postpubertal Girls Treated for Cancer: A Prospective Study
|The Journal of Clinical Endocrinology & Metabolism|2012|202
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance
|Journal of Antimicrobial Chemotherapy|2015|129
Antibiotic susceptibility of planktonic- and biofilm-grown staphylococci isolated from implant-associated infections: should MBEC and nature of biofilm formation replace MIC?
|Journal of Medical Microbiology|2017|49
Biomarkers in bronchiectasis
|European Respiratory Review|2024|31